A man in his mid-70s with a sellar mass.
Jung SM, Hsu YY, Chuang CC, Chang CN, Hsueh C, Kuo TT.
Brain Pathol. 2007 Jan;17(1):115-6, 121. doi: 10.1111/j.1750-3639.2007.00044_1.x.
Cutaneous Myoepithelial Neoplasms on Acral Sites Show Distinctive and Reproducible Histopathologic and Immunohistochemical Features.
Mehta A, Davey J, Gharpuray-Pandit D, Plaza JA, Billings SD, Balogh P, Tchrakian N, Selvan S, Wiedemeyer K, Hornick JL, Brenn T.
Am J Surg Pathol. 2022 Sep 1;46(9):1241-1249. doi: 10.1097/PAS.0000000000001896. Epub 2022 Mar 31.
Postoperative GH and Degree of Reduction in IGF-1 Predicts Postoperative Hormonal Remission in Acromegaly.
Cardinal T, Collet C, Wedemeyer M, Singer PA, Weiss M, Zada G, Carmichael JD.
Front Endocrinol (Lausanne). 2021 Nov 18;12:743052. doi: 10.3389/fendo.2021.743052. eCollection 2021.
Comparative analysis of growth hormone-secreting mixed gangliocytomas and pure growth hormone pituitary adenomas.
Mattheisen H, Peterson A, Memon A, Mrachek EKS, Tavakoli S, Ioachimescu A, Zwagerman N, Cheok S.
Clin Neurol Neurosurg. 2025 Oct;257:109097. doi: 10.1016/j.clineuro.2025.109097. Epub 2025 Aug 5.
Impact of tumor characteristics and pre- and postoperative hormone levels on hormonal remission following endoscopic transsphenoidal surgery in patients with acromegaly.
Cardinal T, Rutkowski MJ, Micko A, Shiroishi M, Jason Liu CS, Wrobel B, Carmichael J, Zada G.
Neurosurg Focus. 2020 Jun;48(6):E10. doi: 10.3171/2020.3.FOCUS2080.
Evaluation of Aggressive Behavior and Invasive Features of Pituitary Adenomas Using Radiological, Surgical, Clinical and Histopathological Markers.
Kucuk A, Bayram F, Ozturk F, Tumturk A, Diri H, Oral S, Tucer B, Durak AC, Kurtsoy A.
Turk Neurosurg. 2016;26(5):671-7. doi: 10.5137/1019-5149.JTN.13161-14.2.
